BRCA

Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy
Chloe Ayres, Gayanie Ratnayake, Orla McNally, Michael Quinn

International Journal of Gynecologic Cancer May 2017, 27 (4) 703-707; DOI: 10.1097/IGC.0000000000000954
The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE)
Takayuki Enomoto, Daisuke Aoki, Kana Hattori, Masahisa Jinushi, Junzo Kigawa, Nobuhiro Takeshima, Hitoshi Tsuda, Yoh Watanabe, Kosuke Yoshihara, Toru Sugiyama

International Journal of Gynecologic Cancer Jul 2019, 29 (6) 1043-1049; DOI: 10.1136/ijgc-2019-000384
A Comprehensive Program Enabling Effective Delivery of Regional Genetic Counseling
Jubilee Brown, Aly Athens, David L. Tait, Erin K. Crane, Robert V. Higgins, R. Wendel Naumann, Lejla Hadzikadic Gusic, Lisa Amacker-North

International Journal of Gynecologic Cancer Jun 2018, 28 (5) 996-1002; DOI: 10.1097/IGC.0000000000001256
BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer
Joanne Kotsopoulos, Karla Willows, Sandra Trat, Raymond H. Kim, Alexandra Volenik, Ping Sun, Steven A. Narod, Jeffrey Boyd, Taymaa May

International Journal of Gynecologic Cancer Jan 2018, 28 (1) 69-76; DOI: 10.1097/IGC.0000000000001144
Improving Referral for Genetic Risk Assessment in Ovarian Cancer Using an Electronic Medical Record System
Sue V. Petzel, Rachel Isaksson Vogel, Jena McNiel, Anna Leininger, Peter A. Argenta, Melissa A. Geller

International Journal of Gynecologic Cancer Jul 2014, 24 (6) 1003-1009; DOI: 10.1097/IGC.0000000000000148
BRCA Germline Mutations in Women With Uterine Serous Carcinoma-Still a Debate
Ofer Lavie, Alon Ben-Arie, Yakir Segev, Jonathan Faro, Frida Barak, Nir Haya, Ron Auslender, Ofer Gemer

International Journal of Gynecologic Cancer Nov 2010, 20 (9) 1531-1534; DOI: 10.1111/IGC.0b013e3181cd242f
Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series
J. S. KWON, J. LENEHAN, M. CAREY, P. AINSWORTH

International Journal of Gynecologic Cancer May 2008, 18 (3) 546-549; DOI: 10.1111/j.1525-1438.2007.01030.x
Effectiveness of Risk-Reducing Salpingo-Oophorectomy in Preventing Ovarian Cancer in a High-Risk French Canadian Population
Omar Moreira Bacha, Jean Gregoire, Katherine Grondin, Maria Isabel Edelweiss, Rachel Laframboise, Jacques Simard, Marie Plante

International Journal of Gynecologic Cancer Jul 2012, 22 (6) 974-978; DOI: 10.1097/IGC.0b013e318257b936
Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?
Karin Leunen, Isabelle Cadron, Toon Van Gorp, Frédéric Amant, Patrick Berteloot, Patrick Neven, Eric Legius, Ignace Vergote

International Journal of Gynecologic Cancer Nov 2009, 19 (9) 1501-1504; DOI: 10.1111/IGC.0b013e3181bb703f
Family History of Cancer Rather Than p53 Status Predicts Efficacy of Pegylated Liposomal Doxorubicin and Oxaliplatin in Relapsed Ovarian Cancer
Maria Ornella Nicoletto, Roberta Bertorelle, Lucia Borgato, Gian Luca De Salvo, Grazia Artioli, Giuseppe Lombardi, Fable Zustovich, Raffaella Marcato, Anna Parenti, Marco Montagna, Martin E. Donach

International Journal of Gynecologic Cancer Jul 2009, 19 (6) 1022-1028; DOI: 10.1111/IGC.0b013e3181a83cb5

Main menu

BRCA

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

BRCA

Pages